BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2459436)

  • 1. [The role of growth factors in proliferating diabetic retinopathy].
    Gaudric A; Barritault D
    Journ Annu Diabetol Hotel Dieu; 1988; ():119-28. PubMed ID: 2459436
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of growth factors in proliferative diabetic retinopathy.
    Forrester JV; Shafiee A; Schröder S; Knott R; McIntosh L
    Eye (Lond); 1993; 7 ( Pt 2)():276-87. PubMed ID: 7607347
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth factors and diabetic retinopathy.
    Paques M; Massin P; Gaudric A
    Diabetes Metab; 1997 Apr; 23(2):125-30. PubMed ID: 9137900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetic retinopathy preproliferating and proliferating. Clinical forms and treatment].
    Guyot-Argenton C
    Journ Annu Diabetol Hotel Dieu; 1988; ():151-61. PubMed ID: 2459437
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth factors in proliferative diabetic retinopathy.
    Khan ZA; Chakrabarti S
    Exp Diabesity Res; 2003; 4(4):287-301. PubMed ID: 14668050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [What is the etiology of diabetic retinopathy?].
    Wiedemann P
    Ophthalmologe; 1993 Oct; 90(5):426-33. PubMed ID: 8219625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel role of erythropoietin in proliferative diabetic retinopathy.
    Takagi H; Watanabe D; Suzuma K; Kurimoto M; Suzuma I; Ohashi H; Ojima T; Murakami T
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S62-4. PubMed ID: 17481772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations on retinal neovascularization.
    Patz A
    Trans New Orleans Acad Ophthalmol; 1983; 31():82-8. PubMed ID: 6194596
    [No Abstract]   [Full Text] [Related]  

  • 9. Vascular endothelial growth factor and retinal neovascularisation: a new therapeutic approach for diabetic retinopathy.
    Favard C; Ortega N; Bayard F; Plouet J
    Diabetes Metab; 1996 Jul; 22(4):268-73. PubMed ID: 8767174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic retinopathy. Pathogenesis and the role of retina-derived growth factor in angiogenesis.
    Sebag J; McMeel JW
    Surv Ophthalmol; 1986; 30(6):377-84. PubMed ID: 2425445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neovascularization and HGF: neovascularization in proliferative diabetic retinopathy and intraocular HGF].
    Nishimura M; Ushiyama M; Nanbu A; Yoshimura M
    Rinsho Byori; 1998 Nov; 46(11):1156-61. PubMed ID: 9868302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of insulin-like growth factor I in the development of diabetic retinopathy].
    Gacka M; Adamiec J
    Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy.
    Hall AP
    Toxicol Pathol; 2006; 34(6):763-75. PubMed ID: 17162534
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recommendation for staging of proliferative diabetic retinopathy].
    Kroll P; Meyer-Rüsenberg HW; Busse H
    Fortschr Ophthalmol; 1987; 84(4):360-3. PubMed ID: 2444521
    [No Abstract]   [Full Text] [Related]  

  • 15. [Growth factors in proliferative diabetic retinopathy].
    Ioniţă M
    Oftalmologia; 1997; 41(3):193-6. PubMed ID: 9409959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenic factors in diabetic ocular disease: mechanisms of today, therapies for tomorrow.
    Robinson GS; Aiello LP
    Int Ophthalmol Clin; 1998; 38(2):89-102. PubMed ID: 9604739
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anatomopathological aspects of diabetic retinopathy].
    Toussaint D; Dhermy P
    Bull Soc Belge Ophtalmol; 1980; (188-189):87-112. PubMed ID: 6166342
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth factors and protein kinase C inhibitors as novel therapies for the medical management diabetic retinopathy.
    Aiello LP; Cahill MT; Cavallerano JD
    Eye (Lond); 2004 Feb; 18(2):117-25. PubMed ID: 14762400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenetic factors for onset of neovascularization in diabetic retinopathy (author's transl)].
    Niki T; Muraoka K; Kitagawa M; Hasunuma T; Tsuji K
    Nippon Ganka Gakkai Zasshi; 1981; 85(7):668-83. PubMed ID: 6171149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.